The US Food and Drug Administration (FDA) staff has raised concerns over the safety of an experimental cancer drug by Spectrum Pharmaceutical and also questioned the benefits the drug provided over existing therapies. The concerns over the cancer drug poziotinib were raised in the US FDA’s briefing documents ahead of a meeting of the regulator’s […]
Continue Reading
Zydus Lifesciences said it has received approval from the US Food and Drug Administration (FDA) to sell Lenalidomide capsules, which are used for the treatment of different types of cancers, in the US market. Zydus Lifesciences received approval from the US FDA to market the product or drug in strengths of 2.5, 5, 10, 15, […]
Continue Reading
The Food and Drug Administration (FDA) of the United States has approved Breckenridge Pharmaceuticals for Cabazitaxel Intravenous Powder, which is used to treat prostate cancer. Natco Pharma, partner of Breckenridge Pharmaceutical Inc. said the US FDA has approved the Abbreviated New Drug Application of Breckenridge for Cabazitaxel Intravenous Power with a 60mg/1.5 mL strength. Natco […]
Continue Reading